157 related articles for article (PubMed ID: 3748485)
21. A comparison between whole body scans made at two hours and three hours after intravenous injection of Tc-99m HDP as to image quality and lesion detectability.
Pauwels EK; Blom J; Aarts JC
Clin Nucl Med; 1984 Feb; 9(2):75-8. PubMed ID: 6713758
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
Coleman RE; Meier CA; Rubens RD; Fogelman I
Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
[TBL] [Abstract][Full Text] [Related]
23. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
[No Abstract] [Full Text] [Related]
24. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
[TBL] [Abstract][Full Text] [Related]
25. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
26. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
[TBL] [Abstract][Full Text] [Related]
28. Localization of 99mTc-diphosphonates in newly formed bone matrix as a measure of bone lesion detectability.
Schuemichen C; Krause T; Umbach G; Wolff T
Nuklearmedizin; 1988 Feb; 27(1):8-11. PubMed ID: 3368337
[TBL] [Abstract][Full Text] [Related]
29. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
[No Abstract] [Full Text] [Related]
30. In vitro stability of 99Tcm bone scan preparations from different manufacturers measured by various radiopharmaceutical parameters.
Pauwels EK; Feitsma RI
Nucl Med Commun; 1984 Jul; 5(7):467-72. PubMed ID: 6099535
[TBL] [Abstract][Full Text] [Related]
31. Bone lesion detection with carrier-added 99mTc-EDTMP in comparison with 99mTc-DPD.
Fueger BJ; Mitterhauser M; Wadsak W; Ofluoglu S; Traub T; Karanikas G; Dudczak R; Pirich C
Nucl Med Commun; 2004 Apr; 25(4):361-5. PubMed ID: 15097810
[TBL] [Abstract][Full Text] [Related]
32. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
33. Tc-99m MDP and indium-111 chloride scintigraphy in skeletal tuberculosis.
Nocera RM; Sayle B; Rogers C; Wilkey D
Clin Nucl Med; 1983 Sep; 8(9):418-20. PubMed ID: 6227442
[TBL] [Abstract][Full Text] [Related]
34. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
[No Abstract] [Full Text] [Related]
35. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
Büll U; Pfeifer JP; Niendorf HP; Tongendorff J
Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
[TBL] [Abstract][Full Text] [Related]
36. Equine skeletal scintigraphy: Comparing normal bone-to-soft tissue ratio 2 and 4 hours after injection with either hydroxymethylene diphosphonate or methylene diphosphonate.
Pelli AC; Winter K; Offhaus J; Brehm W; Gerlach K
Vet Rec; 2022 Nov; 191(10):e2077. PubMed ID: 36000607
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
Yang JS
Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
[No Abstract] [Full Text] [Related]
38. Improved lesion detection with dimethyl-amino-diphosphonate: a report of two cases.
Smith ML; Martin W; McKillop JH; Fogelman I
Eur J Nucl Med; 1984; 9(11):519-20. PubMed ID: 6240401
[TBL] [Abstract][Full Text] [Related]
39. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
40. Increased renal parenchymal accumulation of Tc-99m HDP in kidney contusion.
Salimi Z; Vas W; Tang-Barton P; Suresh P; Carlin B
Clin Nucl Med; 1984 Oct; 9(10):574-6. PubMed ID: 6488654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]